The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study.

Thong, K. Y.; McDonald, Timothy J.; Hattersley, Andrew T.; Blann, A. D.; Ramtoola, S.; Duncan, C.; Carr, S.; Adamson, K.; Nayak, A. U.; Khurana, R.; Hunter, S. J.; Ali, A.; Au, S.; Ryder, R. E. J.

URI

http://hdl.handle.net/11287/618040

Author

Thong, K. Y.

McDonald, Timothy J.

Hattersley, Andrew T.

Blann, A. D.

Ramtoola, S.

Duncan, C.

Carr, S.

Adamson, K.

Nayak, A. U.

Khurana, R.

Hunter, S. J.

Ali, A.

Au, S.

Ryder, R. E. J.

Date

2014-04

Journal

Diabetic medicine : a journal of the British Diabetic Association

Type

Journal Article
Multicenter Study
Observational Study
Research Support, Non-U.S. Gov't

Publisher

Wiley

DOI

10.1111/dme.12367

Rights

Archived with thanks to Diabetic medicine : a journal of the British Diabetic Association

Metadata

Show full item record

Abstract

The response to glucagon-like peptide 1 receptor agonist treatment may be influenced by endogenous β-cell function. We investigated whether urinary C-peptide creatinine ratio assessed before or during liraglutide treatment was associated with treatment response.

Citation

The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study. 2014, 31 (4):403-11 Diabet. Med.

Publisher URL

http://dx.doi.org/10.1111/dme.12367